GE

French government replaces health products agency, gives additional powers

Wednesday, May 2, 2012 11:06 AM

The French government has replaced the French Food Safety Agency of Health Products with the new National Security Agency of Medicines and Health Products (MSNA).

More... »

PRA, Amgen collaborate on biosimilar development program

Wednesday, May 2, 2012 09:18 AM

PRA, a global CRO, has formed a strategic relationship with biotech Amgen for a series of phase III studies to develop several biosimilar drugs on a worldwide basis.

More... »

AMRI hires director of in vitro biology in Singapore

Monday, April 30, 2012 04:41 PM

AMRI, a global CRO, has added Saravanakumar Dhakshinamoorthy, Ph.D., to the ranks of its management team in Singapore, serving as director of in vitro biology.

More... »

Frontage to develop AtheroNova clinical trial supplies

Friday, April 27, 2012 11:59 AM

Frontage, a global CRO based in Ecton, Penn., has signed an agreement to develop clinical trial supplies with AtheroNova, a biotech company focused on R&D of compounds to regress atherosclerotic plaque.

More... »

Oral BG-12 garners positive phase III results in MS

Wednesday, April 25, 2012 12:15 PM

In a second phase III trial (CONFIRM), Biogen Idec’s oral BG-12 (dimethyl fumarate) demonstrated efficacy across a variety of clinical and radiological outcome measures, as well as favorable safety and tolerability profiles in patients with relapsing-remitting multiple sclerosis (RRMS).

More... »

Amgen to acquire Mustafa Nevzat of Turkey

Wednesday, April 25, 2012 10:22 AM

Amgen, a global biotech based in Thousand Oaks, Calif., will acquire 95.6% of shares in Mustafa Nevzat Pharmaceuticals (MN), a privately held Turkish pharmaceutical company, for approximately $700 million. The all-cash transaction will significantly expand Amgen's presence in Turkey and the surrounding region, which are large, fast-growing, priority markets for Amgen.  

More... »

Iris Pharma, RxGen form strategic alliance

Tuesday, April 24, 2012 12:15 PM

Iris Pharma of France, an ophthalmic preclinical and clinical CRO, and RxGen, a Connecticut-based specialty preclinical CRO focused on the development and application of translational research models, have formed a strategic alliance to offer fully integrated “bench-to-bedside” ophthalmology research services.

More... »

HGS refuses GSK unsolicited offer, considers alternatives

Friday, April 20, 2012 11:21 AM

Human Genome Sciences has refused GlaxoSmithKline’s unsolicited offer on April 11 proposing to acquire all of the outstanding shares of HGS for $13.00 per share in cash ($2.6 billion), an 81% premium to closing share price on April 18.

More... »

Thiel Foundation funds six visionary teams in innovation program

Wednesday, April 18, 2012 02:30 PM

The Thiel Foundation has awarded its first six Breakout Labs grants, the company’s revolutionary revolving fund to promote innovation in science and technology.

More... »

CRA wins ViE award for best clinical trial site network

Wednesday, April 18, 2012 01:02 PM

Tempe, Ariz.-based Clinical Research Advantage (CRA), a community-based network of clinical trial sites, has been named best clinical trial site network bythe World Vaccine Congress.

More... »